SELLAS Life Sciences Group, Inc. - Common Stock (SLS)
CUSIP: 81642T209
Q1 2021 13F Holders as of 31 Mar 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 178,475,456
- Total 13F shares
- 1,552,743
- Share change
- +610,168
- Total reported value
- $13,246,990
- Put/Call ratio
- 95%
- Price per share
- $8.54
- Number of holders
- 28
- Value change
- +$5,287,808
- Number of buys
- 18
- Number of sells
- 7
Quarterly Holders Quick Answers
What is CUSIP 81642T209?
CUSIP 81642T209 identifies SLS - SELLAS Life Sciences Group, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 81642T209:
Top shareholders of SLS - SELLAS Life Sciences Group, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
0.32%
|
577,064
|
$3,353,000 | — | 31 Dec 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.06%
|
100,422
|
$583,000 | — | 31 Dec 2020 | |
| Equitable Holdings, Inc. |
13F
|
Company |
0.05%
|
94,300
|
$548,000 | — | 31 Dec 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
34,415
|
$199,000 | — | 31 Dec 2020 | |
| Virtu Financial LLC |
13F
|
Company |
0.01%
|
19,448
|
$113,000 | — | 31 Dec 2020 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.01%
|
19,363
|
$112,000 | — | 31 Dec 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
16,232
|
$94,000 | — | 31 Dec 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.01%
|
16,109
|
$94,000 | — | 31 Dec 2020 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.01%
|
15,409
|
$90,000 | — | 31 Dec 2020 | |
| Engineers Gate Manager LP |
13F
|
Company |
0.01%
|
14,600
|
$85,000 | — | 31 Dec 2020 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.01%
|
10,081
|
$59,000 | — | 31 Dec 2020 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
3,300
|
$19,000 | — | 31 Dec 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1,650
|
$10,000 | — | 31 Dec 2020 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,268
|
$7,000 | — | 31 Dec 2020 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0%
|
704
|
$4,000 | — | 31 Dec 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
400
|
$2,000 | — | 31 Dec 2020 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
310
|
$2,000 | — | 31 Dec 2020 |
Institutional Holders of SELLAS Life Sciences Group, Inc. - Common Stock (SLS) as of Q1 2021
As of 31 Mar 2021,
SELLAS Life Sciences Group, Inc. - Common Stock (SLS) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,552,743 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., SUSQUEHANNA INTERNATIONAL GROUP, LLP, NOMURA HOLDINGS INC, GEODE CAPITAL MANAGEMENT, LLC, Equitable Holdings, Inc., MARSHALL WACE, LLP, Ikarian Capital, LLC, GROUP ONE TRADING, L.P., and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
28
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
17
Q1 2021 holders
28
Holder diff
11
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 Value $ | Q1 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.